Reinsve at 13% to Win 2027 Best Actress Oscar After Buckley Takes 2026

---

Jessie Buckley Just Won the Oscar. So Why Are People Still Betting on Renate Reinsve?

Jessie Buckley won Best Actress at the 98th Academy Awards on March 15, 2026, for her performance in Hamnet, becoming the first Irish actress to claim the honor. The 2026 race is over. Renate Reinsve, nominated for her acclaimed turn in Sentimental Value, lost. And yet a prediction market contract on Reinsve winning Best Actress remains open, actively trading, and priced at 13% implied probability across Kalshi and Polymarket.

Prediction-market view

Live prices, venue by venue

Compare the latest YES price at each venue. Check market rules, liquidity, and fees before trading.

Renate Reinsve

Consensus YES price across 3 venues

3%average

KalshiBest YES price3¢Polymarket US3¢Polymarket3.4¢

Inde Navarrette

Consensus YES price across 2 venues

15%average

KalshiBest YES price15¢Polymarket US15¢

Joan Collins

Consensus YES price across 2 venues

2%average

KalshiBest YES price2¢Polymarket US2¢

Mikey Madison

Consensus YES price across 2 venues

2%average

KalshiBest YES price2¢Polymarket US2¢

Current new-user offer · Kalshi

Get a $35 trading bonusCode PRED35

New users only. Eligibility restrictions and terms apply.

View current offer

That 13% is not a vestige of a dead market. The contract resolves on March 14, 2027, meaning it targets the 99th Academy Awards, a ceremony for which no films have been shortlisted, no nominations announced, and no campaigns launched. Reinsve's price has fallen 8 percentage points from 22% over the past three days, but the decline is not a reaction to bad news about her career. It is the market digesting a simple fact: her strongest nomination cycle to date ended without a win, and the path forward requires an entirely new project, an entirely new campaign, and an entirely new set of competitors.

---

Reinsve at 13%: Reading the Price Chart on a Race With No Contestants

The three-day price trajectory tells a clean story. Reinsve entered the window at 22%, buoyed by residual award-season visibility and name recognition from her Sentimental Value campaign. As the finality of Buckley's victory settled across trading desks, the price shed a third of its value, bottoming at the current 13%.

A notable spread exists between platforms: Kalshi prices Reinsve at 10%, while Polymarket holds her at 16%. That 6-point gap reflects genuine uncertainty about how to value a contender with elite credentials but no confirmed vehicle for the next cycle. Kalshi's lower number suggests its traders weight the absence of a known project more heavily. Polymarket's higher figure may incorporate a premium for Reinsve's demonstrated ability to land Oscar-caliber roles, treating her as a name that could surface quickly once fall festival slates emerge.

The critical detail: nothing negative happened to Reinsve during this window. No bad press, no career misstep, no controversy. Her film Sentimental Value won Best International Feature, making history as the first Norwegian film to claim that prize. She walked the red carpet in a widely praised architectural Louis Vuitton dress that cemented her fashion profile. Her cultural stock is arguably higher today than it was before the ceremony. The price drop is purely structural: the market repriced from "active contender in a live race" to "potential contender in a hypothetical one."

---

What Renate Reinsve Needs to Win the 2027 Oscar, and Why It's Not Impossible

At 13%, the market is saying Reinsve has roughly a 1-in-8 chance of winning Best Actress at the 99th ceremony. That number is neither generous nor dismissive. It reflects a specific set of conditions that would all need to align.

First, she needs a qualifying film. She already has one potential candidate: A24's science fiction horror film Backrooms, released in 2026, which showcases her range beyond European art-house drama. Whether Backrooms carries enough prestige for an Academy campaign is an open question, but A24's track record of converting genre films into awards contenders (think Everything Everywhere All at Once) means it cannot be ruled out.

Second, she has the career arc that the Academy often rewards. Her breakout in Joachim Trier's The Worst Person in the World earned her the Best Actress prize at Cannes in 2021. She was profiled extensively by CBS News during the 2026 cycle as a rising international star. At 39, she is at an age where the Academy's voting demographics historically converge on leading actresses. The pattern of losing a first nomination and winning on a subsequent one is well-documented in Cate Blanchett, Kate Winslet, and Hilary Swank's careers.

Third, the field is empty. No actress has staked a claim on the 2027 race. At this stage in any cycle, implied probabilities are distributed across a wide pool of names, and 13% is a meaningful share of a market with no frontrunner.

---

The Bear Case: Why 13% Might Still Be Too High

The strongest argument against Reinsve at this price is the base rate. In any given year, dozens of actresses deliver Oscar-worthy performances. The probability that any single performer wins the award in a specific year is historically low. Reinsve would need not just a great role but a great role that arrives at the right time, receives the right distributor support, and catches the right cultural moment.

Her international profile, while a strength, is also a structural disadvantage. The Academy has expanded its global membership, but Best Actress remains heavily tilted toward English-language performances. Only two non-English-language performances have ever won the category in the Academy's 98-year history. If Reinsve's next project is another Norwegian-language film, she faces a higher barrier than an American or British peer delivering comparable work.

There is also the possibility that Backrooms, as a genre film, channels attention toward effects and direction rather than lead performance. A24 has won acting Oscars before, but the studio's genre output tends to generate ensemble buzz rather than individual campaigns.

Finally, the 6-point Kalshi-Polymarket spread deserves attention. When platforms disagree this much on a long-dated contract, it often signals thin conviction on both sides. Traders are guessing, not pricing information. That makes the 13% composite figure noisy rather than precise.

---

What This Market Is Really Pricing

The Reinsve contract is not a bet on her talent. Nobody trading this market doubts her ability to deliver an Oscar-caliber performance. It is a bet on whether the film industry will hand her the right vehicle within a specific 12-month window, and whether she can convert that vehicle into a win against an unknown field.

At 13%, the market is saying she's a plausible winner, but the uncertainty is enormous. That feels roughly correct. The open question for traders is whether the Kalshi side (10%) or the Polymarket side (16%) has the better read on how quickly a project could materialize. For Reinsve, the next data point that matters is not a review or a box office number. It is a casting announcement.